|

Fluoxetine Clinical Trials

11 actively recruiting trials across 4 locations

Also known as: Prozac

Pipeline

Early 1: 1Phase 1: 1Phase 2: 2Phase 3: 1Phase 4: 1Phase 1/2: 3

Top Sponsors

  • Tanta University2
  • University of Oxford1
  • University of Maryland, Baltimore1
  • University of Bern1
  • Stanford University1

Indications

  • Depression8
  • Major Depressive Disorder2
  • Depression - Major Depressive Disorder2
  • Anxiety2
  • Illness Anxiety Disorder1

Other7 trials

Dapagliflozin in Depression
Phase 1/2
Fluoxetine on Emotional Experience (FLEX) Study
N/A
Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression
Phase 1/2
Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients
Phase 3
Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)
Phase 1/2
TDM-Guided Treatment With SSRIs in Hospitalized Adults and Children
Phase 4
The Friendship Bench Plus Trial
N/A

Los Angeles, California1 trial

Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer

UCLA / Jonsson Comprehensive Cancer Center

Phase 1

Stanford, California1 trial

Study of Dextromethorphan in OCD and Related Disorders

Stanford University

Phase 2

Baltimore, Maryland1 trial

The Effects of Fluoxetine and/or DHEA

University of Maryland

Early 1

Bethesda, Maryland1 trial

Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

National Institutes of Health Clinical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.